Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
EA
EvodiaBio ApS
aktivCVR 42569283AnpartsselskabIslevdalvej 211, 2610 RødovreForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK -29.7m
Latest period
Source details
Source: dk-regnskabsdata-live-42569283-1793951760248
Document: dk-regnskabsdata-42569283-AZ7PePa6JsD7XaxeV8ut-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: D0
Unit: U-iso4217-DKK
Net result
DKK -26.8m
Latest period
Source details
Source: dk-regnskabsdata-live-42569283-1793951760248
Document: dk-regnskabsdata-42569283-AZ7PePa6JsD7XaxeV8ut-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: D0
Unit: U-iso4217-DKK
Equity
DKK 68.6m
Equity ratio: 76.8%
Source details
Source: dk-regnskabsdata-live-42569283-1793951760248
Document: dk-regnskabsdata-42569283-AZ7PePa6JsD7XaxeV8ut-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: I0
Unit: U-iso4217-DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -6.3m |
| 2023 | — | DKK -14.1m |
| 2024 | — | DKK -21.1m |
| 2025 | — | DKK -26.8m |